Neurolign

Neurolign developed a suite of FDA-cleared neuro-functional diagnostic devices using advanced eye-tracking to assess oculomotor, vestibular, cognitive, and reaction time functions. Their technology has been installed in over 150 sites globally with more than three decades of research backing. The company also launched a consumer device—NeurolignFit™—to bring professional-grade neurological assessments into the home. Clinical studies support their approach for concussion diagnosis/management and broader neurological health applications. In early-stage pharma development or specialty formulations were mentioned but no specific drug programs are public.[2][3]